Mackay Shields LLC’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,200
| Closed | -$297K | – | 741 |
|
|
2021
Q1 | $297K | Sell |
8,200
-6,100
| -43% | -$221K | ﹤0.01% | 1331 |
|
|
2020
Q4 | $415K | Buy |
+14,300
| New | +$415K | ﹤0.01% | 1291 |
|
|
2020
Q2 | – | Sell |
-6,527
| Closed | -$266K | – | 1462 |
|
|
2020
Q1 | $266K | Buy |
6,527
+1,500
| +30% | +$61.1K | ﹤0.01% | 1240 |
|
|
2019
Q4 | $310K | Sell |
5,027
-42,500
| -89% | -$2.62M | ﹤0.01% | 1227 |
|
|
2019
Q3 | $3.46M | Sell |
47,527
-800
| -2% | -$58.3K | 0.02% | 669 |
|
|
2019
Q2 | $3.97M | Buy |
48,327
+43,314
| +864% | +$3.56M | 0.03% | 628 |
|
|
2019
Q1 | $354K | Sell |
5,013
-8,288
| -62% | -$585K | ﹤0.01% | 1248 |
|
|
2018
Q4 | $599K | Sell |
13,301
-7,899
| -37% | -$356K | ﹤0.01% | 1099 |
|
|
2018
Q3 | $1.2M | Sell |
21,200
-31,900
| -60% | -$1.8M | 0.01% | 832 |
|
|
2018
Q2 | $3.55M | Buy |
53,100
+25,300
| +91% | +$1.69M | 0.02% | 594 |
|
|
2018
Q1 | $1.62M | Buy |
+27,800
| New | +$1.62M | 0.01% | 848 |
|